Page last updated: 2024-10-30

letrozole and Stevens-Johnson Syndrome

letrozole has been researched along with Stevens-Johnson Syndrome in 1 studies

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chia, WK1
Lim, YL1
Greaves, MW1
Ang, P1

Other Studies

1 other study available for letrozole and Stevens-Johnson Syndrome

ArticleYear
Toxic epidermal necrolysis in patient with breast cancer receiving letrozole.
    The Lancet. Oncology, 2006, Volume: 7, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Fatal Outcome; Female; Humans; L

2006